Venus Remedies gets nod from Australian authorities for four plants

Drug firm Venus Remedies today said it has received approval from Australian authorities for four of its facilities, thus enabling the company to export products from these facilities to Australia.

The company has received Good Manufacturing Practices (GMP) approval from Therapeutic Goods Administration (TGA) Australia for four of its facilities — Cephalosporin, Carapenems, and Oncology liquid and Oncology lyophilised.

Venus has already filed dossier for meropenem which is on the verge of registration and TGA approval of facility will further expedite the process, it added.

XThese are paid-for links provided by Outbrain, and may or may not be relevant to the other content on this page. To find out more information about driving traffic to your content or to place this widget on your site, visit outbrain.com. You can read Outbrain's privacy and cookie policy here.